193 related articles for article (PubMed ID: 24568842)
1. Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor.
Gibbs PE; Lerner-Marmarosh N; Poulin A; Farah E; Maines MD
FASEB J; 2014 Jun; 28(6):2478-91. PubMed ID: 24568842
[TBL] [Abstract][Full Text] [Related]
2. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.
Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD
FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle Delivered Human Biliverdin Reductase-Based Peptide Increases Glucose Uptake by Activating IRK/Akt/GSK3 Axis: The Peptide Is Effective in the Cell and Wild-Type and Diabetic Ob/Ob Mice.
Gibbs PE; Miralem T; Lerner-Marmarosh N; Maines MD
J Diabetes Res; 2016; 2016():4712053. PubMed ID: 27294151
[TBL] [Abstract][Full Text] [Related]
4. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.
Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
Proc Natl Acad Sci U S A; 2008 May; 105(19):6870-5. PubMed ID: 18463290
[TBL] [Abstract][Full Text] [Related]
5. Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity.
Lerner-Marmarosh N; Shen J; Torno MD; Kravets A; Hu Z; Maines MD
Proc Natl Acad Sci U S A; 2005 May; 102(20):7109-14. PubMed ID: 15870194
[TBL] [Abstract][Full Text] [Related]
6. Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).
Gibbs PE; Miralem T; Lerner-Marmarosh N; Tudor C; Maines MD
J Biol Chem; 2012 Jan; 287(2):1066-79. PubMed ID: 22065579
[TBL] [Abstract][Full Text] [Related]
7. Regulation of TNF-alpha-activated PKC-zeta signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase.
Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
FASEB J; 2007 Dec; 21(14):3949-62. PubMed ID: 17639074
[TBL] [Abstract][Full Text] [Related]
8. Potential application of biliverdin reductase and its fragments to modulate insulin/IGF-1/MAPK/PI3-K signaling pathways in therapeutic settings.
Maines MD
Curr Drug Targets; 2010 Dec; 11(12):1586-94. PubMed ID: 20704544
[TBL] [Abstract][Full Text] [Related]
9. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
Band CJ; Posner BI; Dumas V; Contreres JO
Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
[TBL] [Abstract][Full Text] [Related]
10. The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cδ activity: the peptides are inhibitors or substrate for the protein kinase C.
Miralem T; Lerner-Marmarosh N; Gibbs PE; Tudor C; Hagen FK; Maines MD
J Biol Chem; 2012 Jul; 287(29):24698-712. PubMed ID: 22584576
[TBL] [Abstract][Full Text] [Related]
11. Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways.
Maines MD
Antioxid Redox Signal; 2007 Dec; 9(12):2187-95. PubMed ID: 17919068
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of insulin-like growth factor I receptor tyrosine kinase by ethanol.
Rubin R; Harrison R; Chen XF; Corzitotto J; Hoek JB; Hallak H
Biochem Pharmacol; 2004 Nov; 68(10):2009-17. PubMed ID: 15476672
[TBL] [Abstract][Full Text] [Related]
13. ATP-dependent desensitization of insulin binding and tyrosine kinase activity of the insulin receptor kinase. The role of endosomal acidification.
Contreres JO; Faure R; Baquiran G; Bergeron JJ; Posner BI
J Biol Chem; 1998 Aug; 273(34):22007-13. PubMed ID: 9705342
[TBL] [Abstract][Full Text] [Related]
14. Human biliverdin reductase, a previously unknown activator of protein kinase C betaII.
Maines MD; Miralem T; Lerner-Marmarosh N; Shen J; Gibbs PE
J Biol Chem; 2007 Mar; 282(11):8110-22. PubMed ID: 17227757
[TBL] [Abstract][Full Text] [Related]
15. Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin.
Tudor C; Lerner-Marmarosh N; Engelborghs Y; Gibbs PE; Maines MD
Biochem J; 2008 Aug; 413(3):405-16. PubMed ID: 18412543
[TBL] [Abstract][Full Text] [Related]
16. Krüppel-like factor 14 increases insulin sensitivity through activation of PI3K/Akt signal pathway.
Yang M; Ren Y; Lin Z; Tang C; Jia Y; Lai Y; Zhou T; Wu S; Liu H; Yang G; Li L
Cell Signal; 2015 Nov; 27(11):2201-8. PubMed ID: 26226221
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a small molecule insulin receptor activator.
Salituro GM; Pelaez F; Zhang BB
Recent Prog Horm Res; 2001; 56():107-26. PubMed ID: 11237209
[TBL] [Abstract][Full Text] [Related]
18. Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression.
Miralem T; Gibbs PE; Revert F; Saus J; Maines MD
J Biol Chem; 2010 Apr; 285(17):12551-8. PubMed ID: 20177069
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin.
Kapitulnik J; Maines MD
Trends Pharmacol Sci; 2009 Mar; 30(3):129-37. PubMed ID: 19217170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
